Nature Reviews Drug Discovery, Published online: 04 June 2026; doi:10.1038/d41573-026-00094-6 The ongoing outbreak of Bundibugyo Ebola virus disease in the Democratic Republic of the Congo highlights the urgent need to bridge therapeutic gaps for non-Zaire ebolaviruses by prioritizing and accelerating development and evaluation of broadly applicable and species-specific filovirus countermeasures.